It's not yet Prostate cancer related, but I love it. It is a company traded on Nasdaq, so we are not talking about 3 guys that could be erased by some big pharma company. This is a company I would love to help to get to clinical trials!
The company (I try not to include company names here wen I can) has reported a major breakthrough in AI-driven drug repurposing, identifying potential new treatments for ovarian, colon, and breast cancers.
In just eight weeks, their AI platform analyzed 92 drug-tumor combinations, allowing it to predict outcomes for 964 more, covering nearly 80% of possible experiments—a process that would have taken years in a lab.
Notably, two repurposed drugs outperformed a standard colon cancer treatment in early testing.
The company is also investigating FDA-approved drugs for ovarian cancer, with results expected soon. By accelerating drug discovery by at least 18 months, this approach could revolutionize how new cancer treatments reach patients.
New strategies against bone metastases from prostate cancer - Science Daily
Anyone have prior radiation to your PC diagnosis?
